Dimitriou, Marios
Karolinska Institutet · Pfizer (Sweden)
2 papers on CoChatORCID 0000-0001-8362-2099
Most cited papers
- Verified
Progression in patients with low- and intermediate-1-risk del(5q) myelodysplastic syndromes is predicted by a limited subset of mutations
Scharenberg, C., Giai, V., Pellagatti, A., Saft, L., Dimitriou, M., Jansson, M., Jädersten, M., Grandien, A., Douagi, I., Neuberg, D. S., et al. (2017) · Haematologica
Acute Myeloid Leukemia ResearchRetinoids in leukemia and cellular processes
Cited by 47
- Verified
Identifying therapeutic targets for cancer among 2074 circulating proteins and risk of nine cancers
Smith-Byrne, K., Hedman, Å., Dimitriou, M., Desai, T., Sokolov, A. V., Schioth, H. B., Koprulu, M., Pietzner, M., Langenberg, C., Atkins, J., et al. (2024) · Nature Communications
Genetic Associations and EpidemiologyCancer Genomics and Diagnostics
Cited by 33
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free